James H Ford1, Arveen Kaur1, Deepika Rao1, Aaron Gilson1, Daniel M Bolt2, Helene Chokron Garneau3, Lisa Saldana4, Mark P McGovern3,5. 1. School of Pharmacy, Social and Administrative Sciences Division, University of Wisconsin - Madison. 2. School of Education, Educational Psychology Division, University of Wisconsin - Madison. 3. Center for Behavioral Health Services and Implementation Research, Division of Public Health & Population Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine. 4. Oregon Social Learning Center. 5. Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine.
Abstract
BACKGROUND: The best approach to provide comprehensive care for individuals with co-occurring disorders (CODs) related to substance use and mental health is to address both disorders through an integrated treatment approach. However, only 25% of behavioral health agencies offer integrated care and less than 7% of individuals who need integrated treatment receive it. A project used a cluster-randomized waitlist control group design to evaluate the effectiveness of Network for the Improvement of Addiction Treatment (NIATx) implementation strategies to improve access to addiction and psychotropic medications. METHODS: This study represents a secondary analysis of data from the NIATx project. Forty-nine agencies were randomized to Cohort1 (active implementation group, receiving the NIATx strategy [n=25]) or Cohort2 (waitlist control group [n=24]). Data were collected at three time points (Baseline, Year1 and Year2). A two-level (patient within agency) multinomial logistic regression model investigated the effects of implementation strategy condition on one of four medication outcomes: both medication types, only psychotropic medication, only addiction medication, or neither medication type. A per-protocol analysis included time, NIATx fidelity, and agency focus as predictors. RESULTS: The intent-to-treat analysis found a statistically significant change in access to addiction versus neither medication, but Cohort1 compared to Cohort2 at Year1 showed no differences. Changes were associated with the experimental intervention and occurred in the transition from Year 1 to Year 2, where greater increases were seen for agencies in Cohort2 versus Cohort1. The per-protocol analysis showed increased access to both medications and addiction medications from pre- to post-intervention for agencies in both cohorts; however, differences in change between high- and low-implementation agencies were not significant. CONCLUSIONS: Access to integrated services for people with CODs is a long-standing problem. NIATx implementation strategies had limited effectiveness in improving medication access for individuals with CODs. Implementation strategy adherence is associated with increased medication access.
BACKGROUND: The best approach to provide comprehensive care for individuals with co-occurring disorders (CODs) related to substance use and mental health is to address both disorders through an integrated treatment approach. However, only 25% of behavioral health agencies offer integrated care and less than 7% of individuals who need integrated treatment receive it. A project used a cluster-randomized waitlist control group design to evaluate the effectiveness of Network for the Improvement of Addiction Treatment (NIATx) implementation strategies to improve access to addiction and psychotropic medications. METHODS: This study represents a secondary analysis of data from the NIATx project. Forty-nine agencies were randomized to Cohort1 (active implementation group, receiving the NIATx strategy [n=25]) or Cohort2 (waitlist control group [n=24]). Data were collected at three time points (Baseline, Year1 and Year2). A two-level (patient within agency) multinomial logistic regression model investigated the effects of implementation strategy condition on one of four medication outcomes: both medication types, only psychotropic medication, only addiction medication, or neither medication type. A per-protocol analysis included time, NIATx fidelity, and agency focus as predictors. RESULTS: The intent-to-treat analysis found a statistically significant change in access to addiction versus neither medication, but Cohort1 compared to Cohort2 at Year1 showed no differences. Changes were associated with the experimental intervention and occurred in the transition from Year 1 to Year 2, where greater increases were seen for agencies in Cohort2 versus Cohort1. The per-protocol analysis showed increased access to both medications and addiction medications from pre- to post-intervention for agencies in both cohorts; however, differences in change between high- and low-implementation agencies were not significant. CONCLUSIONS: Access to integrated services for people with CODs is a long-standing problem. NIATx implementation strategies had limited effectiveness in improving medication access for individuals with CODs. Implementation strategy adherence is associated with increased medication access.
Authors: Kim A Hoffman; Carla A Green; James H Ford; Jennifer P Wisdom; David H Gustafson; Dennis McCarty Journal: J Behav Health Serv Res Date: 2012-07 Impact factor: 1.505
Authors: Pia M Mauro; C Debra Furr-Holden; Eric C Strain; Rosa M Crum; Ramin Mojtabai Journal: Drug Alcohol Depend Date: 2016-04-07 Impact factor: 4.492
Authors: Steven Belenko; Christy Visher; Frank Pearson; Holly Swan; Michele Pich; Daniel O'Connell; Richard Dembo; Linda Frisman; Leah Hamilton; Jennifer Willett Journal: AIDS Educ Prev Date: 2017-06
Authors: Helen M Pettinati; David W Oslin; Kyle M Kampman; William D Dundon; Hu Xie; Thea L Gallis; Charles A Dackis; Charles P O'Brien Journal: Am J Psychiatry Date: 2010-03-15 Impact factor: 18.112
Authors: Jennifer Pankow; Jennifer Willett; Yang Yang; Holly Swan; Richard Dembo; William M Burdon; Yvonne Patterson; Frank S Pearson; Steven Belenko; Linda K Frisman Journal: J Behav Health Serv Res Date: 2018-04 Impact factor: 1.505
Authors: James H Ford; Eric L Osborne; Mehret T Assefa; Amy M McIlvaine; Ahney M King; Kevin Campbell; Mark P McGovern Journal: BMC Health Serv Res Date: 2018-06-08 Impact factor: 2.655
Authors: Thomas J Waltz; Byron J Powell; Monica M Matthieu; Laura J Damschroder; Matthew J Chinman; Jeffrey L Smith; Enola K Proctor; JoAnn E Kirchner Journal: Implement Sci Date: 2015-08-07 Impact factor: 7.327
Authors: James H Ford; Hannah Cheng; Michele Gassman; Harrison Fontaine; Hélène Chokron Garneau; Ryan Keith; Edward Michael; Mark P McGovern Journal: Implement Sci Date: 2022-09-29 Impact factor: 7.960